Shilpi Mehrotra
Sr. Project Manager, Chemicals and Materials
As delivery systems move from formulation support to strategic technology platforms, sustainability, substantiated efficacy and ready-to-use solutions are reshaping where premium value is created.
For years, competition in personal care centred on the active ingredient. Retinoids, vitamin C derivatives, peptides and botanical antioxidants provided both the performance story and the marketing language. Suppliers competed on purity, provenance and price; brands competed on the credibility of the claims attached to the molecule.
That model is changing. Performance is increasingly determined not only by the active itself, but by the engineered system that protects it during manufacture and storage, then releases it at the intended site and moment of application. In commercial terms, differentiation is moving from the ingredient to the carrier. In a market estimated at $635 million in 2026, this shift is determining which suppliers, technology specialists and brands will command premium margins over the next decade.
Three forces are now reshaping the category: sustainability as a technical requirement, the shift from ingredient supply to delivery platforms, and rising demand for demonstrable performance across a widening range of applications.
Watch: Why Delivery Systems Matter in Personal Care
Performance in personal care is no longer determined solely by the active ingredient. As brands seek greater efficacy, stability, and measurable results, delivery systems are becoming critical to how ingredients perform on skin and hair.
In this video, Shilpi Mehrotra, Senior Project Manager in Kline and Company’s Chemicals & Materials practice, explains how delivery technologies are helping suppliers and brands improve bioavailability, support targeted delivery, stabilize sensitive actives, and create more differentiated products.
Sustainability Is Now a Design Specification
Sustainability has moved beyond brand positioning to become a core material requirement. Environmental regulation, including restrictions on synthetic microplastics, is pushing suppliers to reformulate shell and matrix materials rather than simply make greener claims. Cellulose-derived microspheres, polysaccharide matrices and other renewable functional materials are gaining importance as the industry searches for biodegradable structures that can maintain performance.
The impact will not be equal across all technologies. Formats that depend on solid synthetic structures, such as visible beads and certain polymer shells, face higher regulatory exposure. Systems based on lipids, surfactants or naturally derived carbohydrates carry less risk. Suppliers that convert their portfolios early can turn compliance into a commercial differentiator; those that move late may find themselves reformulating under pressure. In this market, environmental compliance is becoming a competitive capability.
From Ingredients to Ready-to-Use Platforms
The second shift is commercial as much as technical. Brands are operating on compressed launch cycles and increasingly prefer ready-to-use, pre-loaded and active-integrated delivery systems that can be incorporated directly into formulations. These platforms reduce development complexity, shorten time to market and transfer technical risk to suppliers with the expertise to manage it.
The economics already reflect this migration. Integrated manufacturers that supply both the active and the delivery architecture hold around three quarters of encapsulated category value. In matrix-based systems, service and technology capture more than half of the value. By contrast, suppliers of commodity phospholipids or standard polymers face continued margin pressure.
The implication is clear: companies selling materials into someone else’s system compete on cost, while those selling characterised, ready-to-integrate platforms compete on capability. The move from ingredient supply to platform supply is therefore not a cosmetic repositioning exercise; it is a strategic decision about where in the value pool a company wants to play.
Efficacy Must Be Measurable
The third trend is evidence. Differentiation is shifting from decorative format or ingredient novelty toward controlled-release kinetics, stability data, irritation-reduction evidence and active-specific performance. As regulatory scrutiny increases around nanoscale materials, labelling and claim substantiation, the evidence package becomes part of what a supplier sells.
At the same time, demand is spreading beyond skin care. Skin remains the anchor, especially in premium anti-ageing, brightening and barrier-repair claims, but hair and scalp care is emerging quickly as the “skinification of hair” brings skincare actives into scalp-health and hair-condition positioning. For delivery specialists, this creates an attractive adjacency that can often be addressed with existing technology platforms.
Three Routes to Value
The direction of travel is common, but the value logic differs across encapsulated systems, phospholipid-based and bio-delivery systems, and matrix-based structural systems.
Encapsulation: Scale with a Sustainability Challenge
Encapsulated systems are the largest category. They use core-shell architectures in which an active is physically enclosed within a protective shell made from polymers, carbohydrates, waxes, silicates or clays. These systems are particularly relevant for chemically fragile or irritation-prone actives such as retinol, vitamin C, coenzyme Q10 and salicylic acid, where encapsulation can improve stability, manage release and reduce irritation.
Commercially, encapsulation is where integration has advanced furthest, but it is also where material substitution is most urgent. Solid synthetic shells can fall directly into the line of regulatory attention, making biodegradable alternatives a priority. The category’s next phase will be defined by suppliers that can combine scale, performance and sustainable shell chemistries.
Phospholipid and Bio-Delivery Systems: Premium Science Narratives
Phospholipid-based systems, including liposomes, ethosomes and phytosomes, are sub-micron vesicles formed from amphiphilic lipids or surfactants. Their bilayer structures can carry hydrophilic ingredients in the aqueous core and lipophilic ingredients within the membrane, supporting compatibility with the skin’s lipid environment.
Interest is also rising in biotechnology-led bio-delivery systems, including extracellular vesicles, biomimetic vesicles and carrier or cell-penetrating peptides. Exosomes have attracted particular attention because they combine delivery potential with inherent biological activity, aligning strongly with premium concepts around regenerative beauty, skin longevity, barrier support, soothing and resilience.
Matrix-Based Systems: Smaller Scale, High Differentiation
Matrix-based and structural systems are smaller but highly differentiated. Instead of enclosing the active in a shell, they disperse or support it within a physical structure such as beads, films, patches or microsponges. Beads can provide visual cues in gels and cleansers, while films, patches and microsponges deliver more functional, targeted performance.
Here, value is concentrated less in raw materials than in service, formulation know-how and proprietary platforms. Sustainability pressure on bead materials makes cellulose microspheres and biogenic bead concepts attractive, while active-integrated structural systems offer brands a route to visible, differentiated and easier-to-claim product formats.
Where the Market Goes Next
Across all three categories, the direction is consistent. Growth will be led by sustainable materials, ready-to-use platforms and demonstrable efficacy. The winners will be suppliers that convert environmental pressure into material innovation, sell delivery as an integrated technology rather than a commodity input, and support premium claims with data. In personal care, the carrier is no longer hidden formulation infrastructure. It is becoming one of the main sources of performance, differentiation and value.
Kline has published Delivery Systems in Personal Care which maps four key delivery system categories end to end, technologies, formats, applications, maturity and commercial positioning, alongside the full value chain, competitive ecosystem and regulatory environments. What differentiates the analysis is the grounding of every technology claim in real commercial platforms, launches and investment activity.
